搜索临床试验以:Aliskiren/HCTZ
总计388个结果
-
Novartis Pharmaceuticals终止心血管事件哥伦比亚, 印度, 南非, 加拿大, 西班牙, 匈牙利, 美国, 德国, 爱尔兰, 阿根廷, 菲律宾, 巴西, 瑞典, 马来西亚, 智利, 以色列, 捷克共和国, 荷兰
-
Boryung Pharmaceutical Co., LtdChonbuk National University Hospital; Samsung Medical Center; Asan Medical Center; Chonnam National... 和其他合作者完全的
-
University of South CarolinaDuke University; Kilimanjaro Christian Medical Centre, Tanzania完全的
-
Menarini GroupDaiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company完全的
-
The First Affiliated Hospital of Soochow UniversityZhejiang University; The Second People's Hospital of Huai'an; Soochow Hopes Hematology Hospital; Hygeia Suzhou Yongding Hospital完全的
-
John MascarenhasNational Cancer Institute (NCI); Novartis; Incyte Corporation; Myeloproliferative Disorders-Research...终止
-
Centers for Disease Control and PreventionUniversity of Miami; Nova Southeastern University; DePaul University完全的
-
Joanne Kurtzberg, MDThe Marcus Foundation完全的
-
Joanne Kurtzberg, MDDuke Clinical and Translational Science Institute (CTSI), part of the NIH Clinical and Translational...完全的
-
Centers for Disease Control and PreventionEducation Development Center, Inc.; Callen-Lorde Community Health Center; Hispanic AIDS Forum,...完全的
-
Novartis Pharmaceuticals终止Non-diabetic Nephropathy荷兰
-
Novartis完全的
-
University of MichiganNovartis Pharmaceuticals撤销
-
Daiichi Sankyo, Inc.Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company完全的
-
Novartis完全的
-
Centers for Disease Control and PreventionUniversity of Illinois at Chicago; Howard Brown Health Center; Chicago Department of Public Health 和其他合作者完全的
-
Daiichi Sankyo, Inc.Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company完全的